C
DGX icon

Covestor’s Quest Diagnostics DGX Stock Holding History

Covestor’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Sell
644
-68
-10% -$13.3K 0.08% 220
2026
Q1 		$140K Sell
712
-446
-39% -$86.7K 0.1% 164
2025
Q4 		$201K Buy
1,158
+324
+39% +$59K 0.11% 215
2025
Q3 		$159K Sell
834
-368
-31% -$65.3K 0.09% 311
2025
Q2 		$216K Sell
1,202
-221
-16% -$38.4K 0.13% 147
2025
Q1 		$241K Sell
1,423
-252
-15% -$41.4K 0.16% 103
2024
Q4 		$253K Sell
1,675
-150
-8% -$23.3K 0.16% 95
2024
Q3 		$283K Sell
1,825
-65
-3% -$9.71K 0.18% 72
2024
Q2 		$259K Sell
1,890
-133
-7% -$18.2K 0.17% 94
2024
Q1 		$269K Buy
2,023
+106
+6% +$13.8K 0.17% 69
2023
Q4 		$265K Buy
1,917
+90
+5% +$11.8K 0.18% 65
2023
Q3 		$223K Buy
1,827
+182
+11% +$24.2K 0.17% 82
2023
Q2 		$231K Buy
1,645
+15
+0.9% +$2.07K 0.18% 82
2023
Q1 		$230K Sell
1,630
-87
-5% -$12.4K 0.2% 70
2022
Q4 		$269K Sell
1,717
-72
-4% -$10.3K 0.22% 61
2022
Q3 		$219K Sell
1,789
-92
-5% -$12.1K 0.19% 70
2022
Q2 		$250K Sell
1,881
-26
-1% -$3.54K 0.2% 75
2022
Q1 		$261K Buy
1,907
+857
+82% +$119K 0.17% 81
2021
Q4 		$182K Buy
+1,050
New +$160K 0.26% 37

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Covestor's DGX Position: Q2 2026 in Review

Covestor reduced its Quest Diagnostics (DGX) stake by 9.6% in Q2 2026, selling an estimated $13.3K and leaving 644 shares worth $137K. The position accounts for 0.08% of the portfolio, ranked #220.

Covestor first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $283K in Q3 2024. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Covestor held 644 shares of Quest Diagnostics worth $137K as of Q2 2026.
  • Covestor sold 68 Quest Diagnostics shares in Q2 2026, an estimated $13.3K.
  • Quest Diagnostics made up 0.08% of Covestor's portfolio in Q2 2026, its #220 holding.
  • Covestor first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Quest Diagnostics position peaked at $283K in Q3 2024.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.